🔒 This review discusses the 2024 revision of EU GMP Annex 1, focusing on contamination control and quality risk management in sterile manufact…
High impact 7 min
Updated daily from FDA, EMA, ICH and leading publishers
The pharma industry's research library
Curated regulatory guidance, clinical analyses, and market reports. AI-summarized, editor-reviewed, instantly downloadable.
60whitepapers
8publishers
6regions
Dailyupdates
Research Pulse
Aggregated from live regulatory feeds 60 Research reports In library
8 Publishers FDA, EMA, industry
3 Featured Editor picks
2 Gated downloads Lead-gen reports
Quick answer
NovaPharmaNews hosts 60 curated pharmaceutical whitepapers and industry reports from 8 publishers — FDA and EMA regulatory guidance, clinical analyses, manufacturing intelligence, and market research. 3 featured reports are editor-picked this week. Each landing page includes key takeaways, optional PDF download, and links to related drugs, companies, and pipeline data.
Methodology & data sources Publications & analysis Editorial policy
Trending in pharma research
manufacturingregulatorywww.ist-ag.comAIwww.zs.comclinicalLeary, MichaelEuropean Medicines Agency
Browse the library
60 results 🔒 
🔒 Scientific Standards for 23andMe's Health and Trait Reports
This white paper outlines the scientific standards for 23andMe's genetic health and trait reports, emphasizing validity and evidence-based p…
High impact 4 min
AESGP Position on Commission Proposal for Simplification of MDR
This position paper outlines AESGP's recommendations on simplifying medical device regulations in Europe.
High impact 5 min
This whitepaper discusses strategies for enhancing post-approval compliance in pharmaceuticals through integrated governance and AI.
High impact 5 min
Overview of Comments Received on ICH Q3E Guideline
This document summarizes comments on the ICH Q3E Guideline regarding extractables and leachables, focusing on regulatory and safety consider…
High impact 5 min
Strengthening the FDA's Accelerated Approval Pathway: Progress and Unfinished Business
This whitepaper reviews the FDA's Accelerated Approval pathway, highlighting its evolution, challenges, and proposed reforms.
High impact 5 min
Explore related intelligence
Entity directories linked from research reports and market briefs.
- Browse all topics 216 topic hubs
- Global markets Regional command centers
- Company directory Sponsor profiles
- Drug profiles INN & regulatory status
- Pipeline programs R&D intelligence
- Clinical trials Stage filters
- Publications & analysis Expert commentary
- Regulatory reference Submission pathways
- Data sources Methodology
Frequently asked questions
What whitepapers does NovaPharmaNews publish?
Our research library curates FDA, EMA, and industry publisher PDFs — regulatory guidance, clinical analyses, manufacturing reports, and market intelligence. Each report includes an AI-summarized landing page with key takeaways and a gated PDF download.
How do I download a whitepaper?
Open any report page, scroll to the download form, and enter your work email. You receive instant PDF access and can opt in to weekly pharma intelligence updates. Downloads are free for healthcare professionals.
How do whitepapers connect to news and pipeline data?
Report pages link to related intelligence — company profiles, drug INN pages, clinical trials, pipeline programs, and topic hubs. Use the intelligence spokes on each page to explore the entity graph behind the research.
How often is the library updated?
New reports are ingested daily from leading publishers and regulatory sources. Featured picks highlight high-impact FDA, EMA, and industry research each week.